4//SEC Filing
Koppel Adam 4
Accession 0000899243-23-015220
CIK 0001805387other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:07 PM ET
Size
10.3 KB
Accession
0000899243-23-015220
Insider Transaction Report
Form 4
Koppel Adam
Director10% Owner
Transactions
- Other
Common Stock
2023-06-07−432,627→ 60,199,729 total(indirect: See footnotes) - Award
Common Stock
2023-06-07+3,282→ 3,282 total - Award
Stock Option (Right to Buy)
2023-06-07+13,780→ 13,780 totalExercise: $32.60Exp: 2033-06-07→ Common Stock (13,780 underlying)
Footnotes (4)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 100% of the RSUs subject to this grant shall vest upon the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date.
- [F2]100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date.
- [F3]On June 7, 2023, BC Perception Holdings, LP ("BC Perception") distributed an aggregate of 432,627 shares of the Issuer's common stock (the "Distributed Shares") to certain of its limited partners in a pro-rata in-kind distribution to such limited partners in connection with a redemption of their partnership interests. Dr. Koppel did not have a pecuniary interest in any of the Distributed Shares.
- [F4]Adam Koppel is a Partner of Bain Capital Life Sciences Investors, LLC, which is the ultimate general partner of Bain Capital Life Sciences Fund, L.P. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001578965
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:07 PM ET
- Size
- 10.3 KB